Asthma treatment guidelines 2022 |
Asthma acute management guideline |
Asthma treatment guideline - MART and LAMA |
Prescribe inhaler medication by brand
Key
MDI – Metered dose inhaler
DPI – Dry Powder Inhaler
ICS - Inhaled Corticosteroid
SABA - Short acting Beta2
LABA – Long acting Beta2 Agonists
LAMA – Long acting muscarinic antagonist
Spacer
Aerochamber Flo-VU (only one to be prescribed per year)
Short acting Beta2 Inhalers - For guidance on product choice please see the Asthma Guidelines
Ventolin MDI -Salbutamol
Salamol Easibreathe -Salbutamol
Bricanyl Turbohaler - Terbutaline
Salbutamol Easyhaler -Salbutamol
Inhaled Corticosteroid inhalers- For guidance on product choice please see the Asthma Guidelines
Clenil MDI –Beclometasone
Budesonide easyhaler
Pulmicort Turbohaler – Budesonide
Flixotide MDI - Fluticasone
Qvar MDI – Beclometasone
ICS/LABA Combination inhaler- For guidance on product choice please see the Asthma Guidelines
Fostair MDI – Beclometasone/formoterol
Fostair Nexthaler DPI – Beclometasone/formoterol
Symbicort DPI – Budesonide/formoterol
Flutiform MDI – Fluticasone/formoterol
Flutiform K-haler – Fluticasone/formoterol (for the use in adolescents as an option for those using the Easibreathe device)
Seretide (Fluticasone/salmeterol) MDI/Accuhaler - Restricted use. No new patient to be initiated
LAMA- For guidance on product choice please see the Asthma Guidelines
Spiriva Respimat 2.5 micrograms - Tiotropium
COPD inhaler treatment guidelines |
COPD treatment guidelines - Poster |
Spacer devices leaflet |
Key
MDI – Metered dose inhale
DPI – Dry Powder Inhaler
ICS - Inhaled Corticosteroid
SABA - Short acting Beta2
LABA – Long acting Beta2 Agonists
LAMA – Long acting muscarinic receptor antagonist
First Line - COPD
Short Acting Bronchodilators |
Ventolin MDI 100mcgs |
Salbutamol |
|
Salamol Easibreathe MDI 100mcgs |
Salbutamol |
|
|
Bricanyl Turbohaler 500mcgs |
Terbutaline |
|
|
Salbutamol Easyhaler 100mcgs |
Salbutamol |
|
|
Long Acting Bronchodilators |
Formoterol EasyHaler 12mcgs |
Formoterol |
|
Spiriva Respimat 2.5mcgs |
Tiotropium | ||
Eklira Genuair 322mcgs |
Aclidinium Bromide | ||
Incruse Ellipta 55mcg |
Umeclidinium Bromide | ||
Spiolto Respimat 2.5/2.5mcgs |
Tiotropium |
Olodaterol |
|
Anoro Ellipta 55/22mcg |
Umeclidinium Bromide |
Vilanterol |
|
Duaklir Genuair 340/12 mcgs |
Aclidinium Bromide |
Formoterol |
|
Inhaled Corticosteroids in a combination inhaler (ICS+LABA) |
Symbicort Turbohaler 400/12mcgs |
Formoterol |
Budesonide |
Symbicort MDI 200/6 mcgs |
Formoterol |
Budesonide |
|
Fostair NextHaler 100/6 mcgs |
Formoterol |
Beclometasone ExtraFine |
|
Fostair MDI 100/6 mcgs |
Formoterol | Beclometasone ExtraFine | |
Relvar Ellipta 92/22mcg |
Vilanterol |
Fluticasone Furoate |
Inhaled Corticosteroids in a combination inhaler (ICS/LABA/LAMA) |
||||
Trimbow 87/5/9mcg |
Glycopyrronium |
Formoterol Fumarate |
Beclometasone Extrafine |
|
Trelegy Ellipta 92/55/22mcg |
Umeclidinium |
Vilanterol |
Fluticasone Furoate |
Second Line - COPD
Long Acting Bronchodilator |
Serevent Accuhaler 50mcgs |
Salmeterol |
||
Serevent MDI 25mcgs |
Salmeterol | |||
Inhaled Corticosteroids in a combination inhaler (ICS+LABA) |
||||
Seretide Accuhaler 500/50 mcgs |
Existing Patients Only - part of REVIEW programme |
Salmterol |
Fluticasone Propionate |
PRODUCTS REMOVED FROM FORMULARY:
Onbrez Breezhaler 150 & 300 mcgs (Indacaterol)
Seebri Breezhaler 44mcgs (Glycopyrronium Bromide)
Spiriva Handihaler (Tiotropium)